Skip to main content
OpenTrials

Clinical trial condition

Retroviridae Infections

Explore clinical trials studying Retroviridae Infections. Study availability and eligibility vary by location and protocol.

5,663 public trials 308 recruiting studies
Refine in advanced search Browse all conditions

Retroviridae Infections trial results

Completed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

NCT00098722

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Pfizer Investigational Site Hobson City, Alabama, United States
  • Pfizer Investigational Site Garden Grove, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Oakland, California, United States
View all 172 locations
View Trial Details
Completed

The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

NCT00001035

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +21 more
Locations
  • USC CRS Los Angeles, California, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • NY Univ. HIV/AIDS CRS New York, United States
View Trial Details
Completed

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

NCT01032902

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Univeristy of California, San Diego La Jolla, California, United States
  • Therafirst Fort Lauderdale, Florida, United States
  • University of Maryland Baltimore, Maryland, United States
  • St. Christopher's Hospital for Children/ Drexel University College of Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

NCT00098306

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Pfizer Investigational Site Sacramento, California, United States
  • Pfizer Investigational Site San Francisco, California, United States
  • Pfizer Investigational Site San Francisco, California, United States
  • Pfizer Investigational Site San Francisco, California, United States
View all 22 locations
View Trial Details

Related conditions